Literature DB >> 12643885

Does the discharge ECG provide additional prognostic insight(s) in non-ST elevation ACS patients from that acquired on admission?

A Hersi1, Y Fu, B Wong, K W Mahaffey, R A Harrington, R M Califf, F Van de Werf, P W Armstrong.   

Abstract

BACKGROUND: Although the prognostic value of admission ST changes in patients with non-ST elevation acute coronary syndrome (ACS) is established, the utility of the discharge ECG is unknown. Accordingly, using the PARAGON-B Troponin substudy, we assessed the prevalence of ST depression on both admission and discharge ECG, the likelihood of developing new Q-waves at discharge and the additional prognostic value of these changes. METHODS AND
RESULTS: Nine hundred and eighteen patients were studied; 542 patients (59%) had admission ST downward arrow > or =1mm and 376 patients (41%) did not and their 6-month mortality was 4.4 vs 0.8%, P=0.002, respectively. Of patients with ST downward arrow on admission, 320 (59%) normalized their ST segment at discharge. Of patients without ST downward arrow on admission, 35 (9.3%) developed new ST downward arrow at discharge. Patients with persistent ST downward arrow on discharge had a higher 6-month mortality (6.0 vs 0.9%), (re)MI (16.3 vs 7.4%), and death/(re)MI (20.0 vs 8.3%) than those who never had ST downward arrow (all P< or =0.002). Two hundred and fifty-six patients had Q-waves on admission whereas by discharge 320 had Q-waves. Patients with Q-waves on discharge vs those without had a higher mortality (4.8 vs 1.9%), (re)MI (13.8 vs 8.3%), and death/(re)MI (16.4 vs 9.6%) at 6 months (all P< or =0.021).
CONCLUSIONS: This study highlights that the dynamic ECG changes which occur between admission and discharge in non-ST elevation ACS patients allows further risk stratification in determining the likelihood of 6-month death and/or re(MI).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12643885     DOI: 10.1016/s0195-668x(02)00525-0

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  4 in total

1.  A Predictive Study of the Dynamic Development of the P-Wave Terminal Force in Lead V1 in the Electrocardiogram in Relation to Long-Term Prognosis in Non-ST-Segment Elevation Acute Coronary Syndrome Patients during Hospitalization.

Authors:  Qiao Li; Li-Dan Gu; Chen Zhang; Wei Liu; Yong Peng; Hua Chai; Yuan-Ning Xu; Jia-Fu Wei; Mao Chen; De-Jia Huang
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-02-09       Impact factor: 1.468

2.  Prognostic value of standard electrocardiographic parameters for predicting major adverse cardiac events after acute myocardial infarction.

Authors:  Won Suk Choi; Jang Hoon Lee; Sun Hee Park; Kyun Hee Kim; Jung Kyu Kang; Na Young Kim; Hyun Jun Cho; Jae Yong Yoon; Sang Hyuk Lee; Myung Hwan Bae; Hyeon Min Ryu; Dong Heon Yang; Hun Sik Park; Yongkeun Cho; Shung Chull Chae; Jae-Eun Jun; Wee-Hyun Park
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-01       Impact factor: 1.468

3.  Modified thrombolysis in myocardial infarction (TIMI) risk score to risk stratify patients in the emergency department with possible acute coronary syndrome.

Authors:  Zehra Jaffery; Michael P Hudson; Gordon Jacobsen; Richard Nowak; James McCord
Journal:  J Thromb Thrombolysis       Date:  2007-02-21       Impact factor: 2.300

4.  Complementary prognostic values of ST segment deviation and Thrombolysis In Myocardial Infarction (TIMI) risk score in non-ST elevation acute coronary syndromes: Insights from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) study.

Authors:  Thao Huynh; James Nasmith; The Minh Luong; Martin Bernier; Chantal Pharand; Zhao Xue-Qiao; Robert P Giugliano; Pierre Theroux
Journal:  Can J Cardiol       Date:  2009-12       Impact factor: 5.223

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.